ALGN vs. THC: A Head-to-Head Stock Comparison
UpdatedHere’s a clear look at ALGN and THC, comparing key factors like performance, valuation metrics, dividends, and financial strength. It’s built for investors or anyone curious to see how these two stocks match up.
Company Overview
With ALGN at 12.46 billion USD and THC at 15.12 billion USD, their market capitalizations sit in the same ballpark.
With betas of 1.68 for ALGN and 1.63 for THC, both show similar volatility profiles relative to the overall market.
| Symbol | ALGN | THC |
|---|---|---|
| Company Name | Align Technology, Inc. | Tenet Healthcare Corporation |
| Country | US | US |
| Sector | Healthcare | Healthcare |
| Industry | Medical - Devices | Medical - Care Facilities |
| CEO | Mr. Joseph M. Hogan | Dr. Saumya Sutaria M.D. |
| Price | 171.91 USD | 162.83 USD |
| Market Cap | 12.46 billion USD | 15.12 billion USD |
| Beta | 1.68 | 1.63 |
| Exchange | NASDAQ | NYSE |
| IPO Date | January 30, 2001 | March 17, 1980 |
| ADR | No | No |
Performance Comparison
This chart compares the performance of ALGN and THC over the past year by tracking the growth of an initial $10,000 investment in each (starting one year ago).
Hover over the lines to see the investment’s value and total return (%) at specific dates.
Data is adjusted for dividends and splits.
Valuation Metrics Comparison
For a detailed comparison of valuation metrics between ALGN and THC, please refer to the table below.
| Symbol | ALGN | THC |
|---|---|---|
| Price-to-Earnings Ratio (P/E, TTM) | 30.88 | 10.55 |
| Forward PEG Ratio (TTM) | 2.92 | 0.48 |
| Price-to-Sales Ratio (P/S, TTM) | 3.13 | 0.74 |
| Price-to-Book Ratio (P/B, TTM) | 3.33 | 3.67 |
| Price-to-Free Cash Flow Ratio (P/FCF, TTM) | 19.76 | 10.64 |
| EV-to-EBITDA (TTM) | 14.56 | 5.70 |
| EV-to-Sales (TTM) | 2.94 | 1.23 |
| EV-to-Free Cash Flow (TTM) | 18.56 | 17.79 |
Dividend Comparison
Neither ALGN nor THC currently pays a dividend yield; this often indicates they are reinvesting earnings for growth, prioritizing long-term expansion over immediate cash returns to shareholders.
| Symbol | ALGN | THC |
|---|---|---|
| Dividend Yield (TTM) | 0.00% | 0.00% |
Financial Strength Metrics Comparison
This section dives into the financial resilience of ALGN and THC, spotlighting key metrics like liquidity, leverage, and debt coverage. Check out the standout observations below where notable differences or extremes pop up.
- THC is highly leveraged (debt-to-equity ratio 3.15), elevating both potential gains and risks, compared to ALGN at 0.03, which maintains a steadier capital structure.
- ALGN shows “--” for interest coverage, hinting at negligible interest costs, whereas THC (at 5.80) covers its interest obligations.
| Symbol | ALGN | THC |
|---|---|---|
| Current Ratio (TTM) | 1.21 | 1.78 |
| Quick Ratio (TTM) | 1.08 | 1.70 |
| Debt-to-Equity Ratio (TTM) | 0.03 | 3.15 |
| Debt-to-Assets Ratio (TTM) | 0.02 | 0.45 |
| Interest Coverage Ratio (TTM) | -- | 5.80 |